Administration Declines to Issue FDA Guidance on LDT Oversight
The U.S. Food & Drug Administration (FDA) announced today that it will not release final guidance on oversight of laboratory developed tests (LDTs) that are used for making critical diagnostic and treatment decisions made by patients and their health care providers.

